Cancer kills almost 10 million people globally every year, making it a leading cause of death. Some 90 % of these deaths occur in people who initially responded well to treatment, but whose cancer subsequently became resistant to treatment. The source of this drug resistance lies in rare cancer cells called ‘drug tolerant persister’ cells, or DTPs. Studies show that DTPs survive...

The recurrence of cancer after periods of remission remains the main clinical problem. Scientists have found that some cancer cells become inactive and hibernate-like. Inactive cancer cells go into sleep mode after treatment and can “wake up” years or even decades later, thus allowing cancer to relapse. Decoding what activates cancer cells to reactivate and proliferate is a pivotal...

"Executive Summary Cold Agglutinin Disease Market :  Data Bridge Market Research analyses that the cold agglutinin disease market was valued at USD 72 million in 2021 and is expected to reach USD 293.46 million by 2029, registering a CAGR of 19.20% during the forecast period of 2022 to 2029. The base year for calculation in Cold Agglutinin Disease Market business report is...